Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJRegenMed
Logo
  • Home (current)
  • Specialties
    Hematology
    Oncology
    Musculoskeletal Disorder
    Rare Disease
    Metabolic Disorder
    Cardiovascular Disease
    Ophthalmology
    Neurology
    Infectious Disease
    View all Specialties
  • Technologies
    Cell Therapy
    MSC
    iPSC
    Gene Therapy
    Genome Editing
    Extracellular Vesicles
    CAR-T Therapy
    TCR Therapy
    Tissue-Engineering & Biomaterials
    View all Technologies
  • Topics
    Treatment
    Immuno-Oncology
    Trial Updates
    Perspectives
    Manufacturing
    COVID-19
    View all Topics
  • Conferences
    ASH 2022
    TCT 2022
    Meeting on the Med 2022
    ICLE 2022
    Advanced Therapies Week 2022
    TERMIS 2021
    ESGCT 2021
    Meeting on the Mesa 2021
    Advanced Therapies 2021
    View all Conferences
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Mesenchymal Stem Cells

CYP-001 in adults with steroid-resistant GvHD 3:00
CYP-001 in adults with steroid-resistant GvHD
Ross Macdonald • 19 Apr 2022
SCUlpTOR: CYP-004 in osteoarthritis 2:56
SCUlpTOR: CYP-004 in osteoarthritis
Ross Macdonald • 19 Apr 2022
Addressing challenges in using MSCs in cell therapies 3:00
Addressing challenges in using MSCs in cell therapies
Ross Macdonald • 19 Apr 2022
Generating iSPC-derived MSCs with the Cymerus™ Platform 2:34
Generating iSPC-derived MSCs with the Cymerus™ Platform
Ross Macdonald • 19 Apr 2022
Addressing issues associated with bringing iSPC-derived MSCs to the clinic 0:44
Addressing issues associated with bringing iSPC-derived MSCs to the clinic
Tony Ting • 26 Jan 2022
Enhancing the therapeutic capacity of MSCs 1:48
Enhancing the therapeutic capacity of MSCs
Tony Ting • 26 Jan 2022
Evaluating the development of iSPC-derived MSCs 0:39
Evaluating the development of iSPC-derived MSCs
Tony Ting • 26 Jan 2022
Exploring stem cell-based therapies in osteoarthritis 6:46
Exploring stem cell-based therapies in osteoarthritis
Jiao Jiao Li • 17 Nov 2021
EV-based therapies for myocardial infarction 1:30
EV-based therapies for myocardial infarction
Marta Monguió-Tortajada • 24 Nov 2021
The benefits of extracellular vesicle-based therapies 1:28
The benefits of extracellular vesicle-based therapies
Marta Monguió-Tortajada • 24 Nov 2021
Determining the metabolic requirements for stem cell survival 3:03
Determining the metabolic requirements for stem cell survival
Melvin Gurian • 22 Nov 2021
Overcoming barriers to tendon regeneration 1:58
Overcoming barriers to tendon regeneration
Ilze Donderwinkel • 22 Nov 2021
Evolution of cell therapy for cardiovascular disease 5:24
Evolution of cell therapy for cardiovascular disease
Stefan Janssens • 4 Jun 2021
The role of stem cells in treating CNS disorders 4:07
The role of stem cells in treating CNS disorders
Anne des Rieux • 25 Nov 2021
The future of regenerative medicine in transplantation 4:31
The future of regenerative medicine in transplantation
Giuseppe Orlando • 11 Nov 2021
Developing iPSC-derived MSCs for therapeutic purposes 1:45
Developing iPSC-derived MSCs for therapeutic purposes
Miguel Forte • 5 Oct 2021
  • 1
  • 2
  • 3
  • Next
Journal Pages
  • Specialties
  • Technologies
  • Topics
  • Conferences
Newsletter

Receive the latest news and videos from VJRegenMed via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJRegenMed logo
The content of VJRegenMed is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy